Latest News

Aurealis Therapeutics and Xbiome Enter into a License and Collaboration Agreement for Aurealis Four-in-One Diabetic Foot Ulcer and Inflammatory Disease Cell and Gene Therapy AUP-16 in Greater China

BASEL, Switzerland, KUOPIO, Finland, and SHENZHEN, China, Jan. 29, 2022 /PRNewswire/ -- Aurealis Therapeutics, a synthetic biology company developing groundbreaking four-in-one cell and gene therapies and Xbiome, an AI-based microbiome drug development company, today announced that the two compan...

2022-01-29 05:28 5061

Organic fireworks SPARK as a new sustainable celebration

ROTTERDAM, Netherlands, Jan. 29, 2022 /PRNewswire/ -- How can we celebrate sustainably? Artist Daan Roosegaarde became inspired by the magical light of fireflies, and a desire to update the culturally ingrained ritual of fireworks. The result is SPARK Bilbao, a poetic performance of thousands of ...

2022-01-29 05:12 5262

Corporate Compliance Services set to go Digital in Singapore: HeySara's FAST App will empower entrepreneurs to be more efficient with a new digital platform

SINGAPORE, Jan. 28, 2022 /PRNewswire/ -- HeySara, the leading innovator in the Corporate Compliance space is proud to announce the launch of the FAST App. The FAST, which is the acronym for Financial, Analytics, Secretarial Services, and Taxation, will empower entrepreneurs to simplify their comp...

2022-01-28 23:27 5217

Bon Natural Life Limited Announces FY2021 Earnings Release Date and Webcast

* Earnings to be released before market opens on Monday, January 31, 2022 XI'AN, China, Jan. 28, 2022 /PRNewswire/ -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, will ...

2022-01-28 22:00 6872

CTB001, Bioheng auto CAR - T Product, received Orphan Drug Designation (ODD) from the U.S. FDA

NANJING, China, Jan. 28, 2022 /PRNewswire/ -- Recently, Nanjing Bioheng Biotech Co.,Ltd. ( hereinafter referred to as Bioheng) announced that its anti-claudin 18.2 autologous CAR-T cell therapy product CTB001 received Orphan Drug Designation (ODD) from the Food and Drug Administration (FDA) for t...

2022-01-28 22:00 3945

Yunji's Private Label Food Brands Are a Hit With Members During 2022 Online Lunar New Year Shopping Festival

HANGZHOU, China, Jan. 28, 2022 /PRNewswire/ -- Yunji Inc. ("Yunji" or the "Company") (NASDAQ: YJ), a leading membership-based social e-commerce platform, announced that it will continue to provide its e-commerce service to its platform members during the China Ministry of Commerce's 2022 Online L...

2022-01-28 22:00 3418

CLPS Incorporation Announces Chairman's Letter to the Company's Shareholders

HONG KONG, Jan. 28, 2022 /PRNewswire/ -- CLPS Incorporation (Nasdaq: CLPS) ("CLPS" or "the Company"), today released a letter to shareholders from the Chairman of the Company's Board of Directors (the "Board"), the full text of which is provided below. All CLPS shareholders are encouraged to read...

2022-01-28 21:30 7747

Yili Holds Its Annual Meeting Online - Over RMB 1.2 Billion Worth of Employee Incentives Provided in 2021

* Last year, Yili embarked upon a new journey and achieved the best operating performance ever * Yili has achieved high-quality development and rewarded its employees, the industry chain and society HUHHOT, China, Jan. 28, 2022 /PRNewswire/ -- On January 25, 2022, Yili held its 2021 annual me...

2022-01-28 21:16 6814

Universiti Teknologi Malaysia Solar Energy Technology Transfer Projects Prospering Communities

JOHOR BAHRU, Malaysia, Jan. 28, 2022  /PRNewswire/ -- Recently, UTM's School of Electrical Engineering researchers have installed solar panels on fishing boats to replace the use of diesel mainly for environmental sustainability purpose. Universiti Teknologi Malaysia (UTM) is a research universit...

2022-01-28 21:08 7055

I-Mab Announces Partnership Agreement to Localize Manufacturing and Accelerate Commercialization of Innovative Biologics Drugs

SHANGHAI and GAITHERSBURG, Md., Jan. 28, 2022 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, announced the signing of a partnership agreement with the Hangzhou Qian...

2022-01-28 21:00 3248

China Matters presents 'Zhongshan Efficiency'

BEIJING, Jan. 28, 2022 /PRNewswire/ -- What is 'Zhongshan Efficiency'? In Zhongshan City of Guangdong Province, it takes only five minutes to change the legal representative on a business license. It takes only 10 minutes for the government to solve problems for enterprises on a breakfast meeting...

2022-01-28 20:48 2957

Much Awaited, Much Needed: TRANSFORM II Randomized Controlled Trial, by Fondazione RIC, gets rolling

MILANO, Italy, Jan. 28, 2022 /PRNewswire/ -- FONDAZIONE Ricerca e Innovazione Cardiovascolare,Milano, focused on cardiovascular research, reports the first patient enrolment of theTRANSFORM II Randomized Controlled Trial (Sirolimus-coa...

2022-01-28 20:34 5622

First High-School Education Group's Voluntary Update on Operation

BEIJING, Jan. 28, 2022 /PRNewswire/ -- First High-School Education Group Co., Ltd. ("First High-School Education Group" or the "Company") (NYSE: FHS), an education service provider primarily focusing on high schools inWestern China, today announced its voluntary update on Company's business opera...

2022-01-28 20:30 6096

Skillful Craftsman to Acquire Controlling Interest of Major Flexible Staffing Platform in Jiangsu Province to Expand Online Business Presence Domestically

WUXI, China, Jan. 28, 2022 /PRNewswire/ -- Skillful Craftsman Education Technology Ltd. (the "Company") (NASDAQ: EDTK), an education technology company providing interactive online learning services, announced that onJanuary 28, 2022 the Company entered into an equity transfer agreement (the "Agr...

2022-01-28 20:30 5875

Euroclear group reports another record year and delivery of financial targets two years ahead of plan

Results for the Year Ending 31 December 2021 BRUSSELS, Jan. 28, 2022 /PRNewswire/ -- Highlights                   Full year revenue growth stronger than expected  * Operating income up +9% year-on-year * Business income up +15% year-on-year,  with operating metrics growing strongly - Asse...

2022-01-28 20:08 4594

Alterity Therapeutics Announces Publication Demonstrating that ATH434 is Neuroprotective in Animal Model of Parkinsonian Disorder in the Journal of Parkinson's Disease

MELBOURNE, Australia, Jan. 28, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that data in an animal model of Multiple S...

2022-01-28 20:08 3035

Autoliv: Financial Report October - December 2021

STOCKHOLM, Jan. 28, 2022 /PRNewswire/ --  (NYSE: ALV) and (SSE: ALIV.sdb)  Q4 2021: Solid profitability and cash flow Financial highlights Q4 2021 $2,119m net sales  16% organic sales decline* 8.2% operating margin  8.3% adjusted operating margin*  $1.31 EPS - a decrease of $0.84 $1.30 adjus...

2022-01-28 19:44 3837

Huawei Strengthens Support for ASEAN Economic Community's Industry 4.0 Roadmap and Joint Commitment

KUALA LUMPUR, Malaysia, Jan. 28, 2022 /PRNewswire/ -- Having adopted the Consolidated Strategy on the Fourth Industrial Revolution (4IR) at the 38th ASEAN Summit in October last year, ASEAN organised a socialisation webinar for the Strategy, themed: 'Embracing the 4IR: Outlook, Strategies, and Pl...

2022-01-28 19:12 4969

"Don't forget leprosy" campaign gathers pace as World Leprosy Day approaches

TOKYO, Jan. 28, 2022 /PRNewswire/ -- Sasakawa Leprosy (Hansen's Disease) Initiative is collaborating with 32 organizations from 13 countries to promote the message "Don't forget leprosy" in the run-up to World Leprosy Day onJanuary 30. The international campaign includes awareness-raising events ...

2022-01-28 19:00 2333

LambdaTest Announces Integration with Datadog

This integration will enable better monitoring and collaboration in the DevOps teams SAN FRANCISCO, Jan. 28, 2022 /PRNewswire/ -- LambdaTest, a leading test execution platform, announced an integration withDatadog , Inc. (NASDAQ: DDOG), the monitoring and security platf...

2022-01-28 18:00 9014